Sildenafil 40mg + tadalafil 4mg + vardenafil 7.5mg + apomorphine 2mg in one rapid-dissolve tablet, available only if prescribed after provider review.
From $119 for 6 doses
A PDE5 inhibitor that supports blood flow by blocking the PDE5 enzyme, one of the most commonly prescribed ED ingredients in use.
A second PDE5 inhibitor, included here at a low dose. Within the class, tadalafil is known for its long duration window.
A third PDE5 inhibitor, known in the class for its selectivity for the PDE5 enzyme. It works through the same blood-flow pathway as sildenafil and tadalafil.
Acts on dopamine receptors in the central nervous system involved in sexual-response signaling, adding a central pathway alongside the three blood-flow ingredients.
Three PDE5 inhibitors — sildenafil, tadalafil, and vardenafil — plus apomorphine, which acts on dopamine receptors involved in sexual-response signaling.
An option a provider may consider when a patient has already tried other therapies and a combination approach is appropriate.
Designed to dissolve in the mouth without water and be taken as directed by your provider.
Prescribed only after a full review of your history and prior treatment response.
A 5-minute online health questionnaire — no appointment, no waiting room.
A licensed provider in your state reviews your history and prescribes if appropriate.
Your medication ships from a licensed U.S. pharmacy in discreet packaging.
Message your care team anytime. Dose adjustments and refills handled online.
Your assessment takes about 5 minutes. A licensed provider reviews your information and determines whether treatment is appropriate.
Start Assessment — provider will determine if appropriate →
Tadalafil 20mg + sildenafil 70mg in one rapid-dissolve tablet — combining sildenafil and tadalafil in a compounded formula when prescribed by a licensed provider.
Sildenafil 80mg paired with pycnogenol 50mg in a rapid-dissolve tablet, available when prescribed after provider review.
PT-141 (bremelanotide) is a subcutaneous injection that acts on melanocortin pathways in the central nervous system, prescribed when a licensed provider determines it is appropriate.